Cognit.AI is a company that focuses on computational genomics, using in-silico modeling and cutting-edge artificial intelligence, math, and physics modeling to optimize research in genomics. By consolidating and optimizing AI modeling, Cognit.AI reduces costs and accelerates research in drug discovery, pre-clinical trials, and identifying multi-omics biomarkers and fine-mapping diseases. Their innovative approach helps life sciences keep up with advancements in AI while also focusing on biology.